The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-Acetyl-N-methyl-3-(7-methoxy-1-methyl-beta-carbolin-9-yl)propylamine ID: ALA4552025
PubChem CID: 155555367
Max Phase: Preclinical
Molecular Formula: C19H23N3O2
Molecular Weight: 325.41
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccc2c3ccnc(C)c3n(CCCN(C)C(C)=O)c2c1
Standard InChI: InChI=1S/C19H23N3O2/c1-13-19-17(8-9-20-13)16-7-6-15(24-4)12-18(16)22(19)11-5-10-21(3)14(2)23/h6-9,12H,5,10-11H2,1-4H3
Standard InChI Key: SYQIIYUWXQPERX-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
12.9498 -4.5729 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9487 -5.3925 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6567 -5.8014 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6549 -4.1641 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3636 -4.5693 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3638 -5.3925 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1468 -5.6467 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.1464 -4.3148 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6274 -4.9818 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4436 -4.8979 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7798 -4.1477 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.2937 -3.4805 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4792 -3.5677 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9223 -5.5602 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2407 -5.8005 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.5333 -5.3913 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4004 -6.4235 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8544 -7.0316 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1079 -7.8084 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5619 -8.4164 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.8155 -9.1933 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6151 -9.3621 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.2695 -9.8013 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7624 -8.2476 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 9 1 0
8 5 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 8 1 0
10 14 1 0
2 15 1 0
15 16 1 0
7 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 22 2 0
21 23 1 0
20 24 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 325.41Molecular Weight (Monoisotopic): 325.1790AlogP: 3.37#Rotatable Bonds: 5Polar Surface Area: 47.36Molecular Species: NEUTRALHBA: 4HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 6.11CX LogP: 1.38CX LogD: 1.36Aromatic Rings: 3Heavy Atoms: 24QED Weighted: 0.72Np Likeness Score: -0.51
References 1. Kumar K, Wang P, Wilson J, Zlatanic V, Berrouet C, Khamrui S, Secor C, Swartz EA, Lazarus M, Sanchez R, Stewart AF, Garcia-Ocana A, DeVita RJ.. (2020) Synthesis and Biological Validation of a Harmine-Based, Central Nervous System (CNS)-Avoidant, Selective, Human β-Cell Regenerative Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase A (DYRK1A) Inhibitor., 63 (6): [PMID:32003560 ] [10.1021/acs.jmedchem.9b01379 ]